{"id":"https://openalex.org/W1998690273","doi":"https://doi.org/10.3109/13645709809152905","title":"New strategies for the genetic therapy of primary liver carcinoma","display_name":"New strategies for the genetic therapy of primary liver carcinoma","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W1998690273","doi":"https://doi.org/10.3109/13645709809152905","mag":"1998690273"},"language":"en","primary_location":{"id":"doi:10.3109/13645709809152905","doi":"https://doi.org/10.3109/13645709809152905","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13645709809152905","pdf_url":null,"source":{"id":"https://openalex.org/S144845167","display_name":"Minimally Invasive Therapy & Allied Technologies","issn_l":"0961-625X","issn":["0961-625X","1364-5706","1365-2931"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minimally Invasive Therapy &amp; Allied Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011943968","display_name":"Ulrich M. Lauer","orcid":"https://orcid.org/0000-0002-4557-7730","observed_orcids":["https://orcid.org/0000-0002-4557-7730"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U. Lauer","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073408781","display_name":"Martin Spiegel","orcid":"https://orcid.org/0000-0001-6937-9635","observed_orcids":["https://orcid.org/0000-0001-6937-9635"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Spiegel","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001814278","display_name":"Michael Bitzer","orcid":"https://orcid.org/0000-0002-4463-8263","observed_orcids":["https://orcid.org/0000-0002-4463-8263","https://orcid.org/0000-0002-5990-4878"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Bitzer","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111638002","display_name":"Wolfgang A. Wybranietz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. A. Wybranietz","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102091714","display_name":"Ch. D. Gross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ch. D. Gross","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011978881","display_name":"Florian Prinz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"F. Prinz","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087236043","display_name":"Florian Graepler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"F. Graepler","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113578081","display_name":"Wolfgang J. Neubert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150093","display_name":"Max Planck Institute of Biochemistry","ror":"https://ror.org/04py35477","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210150093"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. J. Neubert","raw_affiliation_strings":["Max-Planck-lnstitute for Biochemistry, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max-Planck-lnstitute for Biochemistry, Martinsried, Germany","institution_ids":["https://openalex.org/I4210150093"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109125166","display_name":"Michael Gregor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Gregor","raw_affiliation_strings":["Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Eberhard-Karls-University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12282666,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"6","first_page":"567","last_page":"571"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-liver-cancer","display_name":"primary liver cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9419999718666077},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/suicide-gene","display_name":"suicide gene","score":0.9789999723434448},{"id":"https://openalex.org/keywords/prodrug-activation","display_name":"prodrug activation","score":0.8960000276565552},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.9990000128746033},{"id":"https://openalex.org/keywords/asialoglycoprotein-receptor","display_name":"asialoglycoprotein receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vp22","display_name":"VP22","score":0.7329999804496765},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.8835316300392151},{"id":"https://openalex.org/C2780127873","wikidata":"https://www.wikidata.org/wiki/Q1055751","display_name":"Sendai virus","level":3,"score":0.7697798013687134},{"id":"https://openalex.org/C11569505","wikidata":"https://www.wikidata.org/wiki/Q727265","display_name":"Asialoglycoprotein receptor","level":4,"score":0.663131833076477},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.55640709400177},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5401657223701477},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5162234306335449},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.49292922019958496},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.48418429493904114},{"id":"https://openalex.org/C97380033","wikidata":"https://www.wikidata.org/wiki/Q994215","display_name":"Viral envelope","level":3,"score":0.43605440855026245},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4269696772098541},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4218311607837677},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.3905927538871765},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.36718034744262695},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2861630320549011},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20362558960914612},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10377344489097595},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.09285229444503784}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3109/13645709809152905","doi":"https://doi.org/10.3109/13645709809152905","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13645709809152905","pdf_url":null,"source":{"id":"https://openalex.org/S144845167","display_name":"Minimally Invasive Therapy & Allied Technologies","issn_l":"0961-625X","issn":["0961-625X","1364-5706","1365-2931"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minimally Invasive Therapy &amp; Allied Technologies","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W17151634","https://openalex.org/W234448542","https://openalex.org/W1485636993","https://openalex.org/W1489436358","https://openalex.org/W1976822357","https://openalex.org/W1980601547","https://openalex.org/W2006217850","https://openalex.org/W2013694858","https://openalex.org/W2017469703","https://openalex.org/W2019754652","https://openalex.org/W2019863692","https://openalex.org/W2020756119","https://openalex.org/W2021699860","https://openalex.org/W2023962152","https://openalex.org/W2039344241","https://openalex.org/W2047010680","https://openalex.org/W2079298198","https://openalex.org/W2095457719","https://openalex.org/W2101286650","https://openalex.org/W2135916975","https://openalex.org/W2166497056","https://openalex.org/W2427176710","https://openalex.org/W2431702822","https://openalex.org/W2473509257"],"related_works":["https://openalex.org/W1017350226","https://openalex.org/W2376267978","https://openalex.org/W2665973600","https://openalex.org/W2053005914","https://openalex.org/W2415918394","https://openalex.org/W2133808164","https://openalex.org/W2619802703","https://openalex.org/W63915740","https://openalex.org/W2091055906","https://openalex.org/W2121030043"],"abstract_inverted_index":{"SummaryGenetically-based":[0],"strategies":[1],"open":[2],"up":[3],"new":[4,54,86],"perspectives":[5],"for":[6],"the":[7,28,57,65,76,133,147],"therapy":[8],"of":[9,30,52,59,69,121,150],"primary":[10],"liver":[11,77],"carcinoma.":[12],"Suicide":[13],"genes":[14,123],"specifically":[15],"targeted":[16],"to":[17,22,27,46,125,140],"hepatoma":[18,152],"cells":[19,36],"are":[20],"able":[21],"activate":[23],"innocuous":[24],"prodrugs,":[25],"leading":[26],"toxification":[29],"genetically-modified":[31],"as":[32,34,132],"well":[33],"neighbouring":[35],"(bystander":[37],"effect).":[38],"Since":[39],"serious":[40],"local":[41],"and":[42,97,110,118],"systemic":[43],"side-effects":[44],"have":[45,83],"be":[47,126],"avoided,":[48],"in":[49,146],"vivo":[50],"application":[51,113],"this":[53],"strategy":[55],"requires":[56],"generation":[58],"hepatotropic":[60,93],"vector":[61,90,112],"systems.":[62],"Based":[63],"on":[64],"distinct":[66],"ligand-receptor":[67],"interaction":[68],"Sendai":[70,94],"virus":[71,95],"F":[72],"envelope":[73],"protein,":[74],"with":[75,103],"specific":[78],"asialoglycoprotein":[79],"receptor":[80],"(ASGP-R),":[81],"we":[82],"developed":[84],"two":[85],"ASGP-R":[87],"restricted":[88],"viral":[89],"systems:":[91],"recombinant":[92],"vectors":[96],"retroviral":[98],"MoMLV(SeV-F)":[99],"pseudotypes.":[100],"In":[101],"combination":[102],"hepatoma-specific":[104],"expression":[105],"cassettes,":[106],"currently":[107],"under":[108],"development,":[109],"topical":[111],"techniques,":[114],"an":[115],"efficient,":[116],"safe":[117],"hepatoma-restricted":[119],"transfer":[120],"therapeutic":[122],"seems":[124],"achievable.":[127],"New":[128],"molecular":[129],"principles,":[130],"such":[131],"VP22":[134],"potentiated":[135],"bystander":[136],"effect,":[137],"might":[138],"help":[139],"achieve":[141],"major":[142],"clinical":[143],"progress,":[144],"especially":[145],"adjuvant":[148],"treatment":[149],"microscopic":[151],"nodules.":[153]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}
